Colonial Trust Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.39M | Sell |
31,947
-1,439
| -4% | -$246K | 0.42% | 69 |
|
|
2025
Q4 | $5.63M | Sell |
33,386
-792
| -2% | -$129K | 0.42% | 69 |
|
|
2025
Q3 | $4.93M | Sell |
34,178
-1,852
| -5% | -$253K | 0.38% | 73 |
|
|
2025
Q2 | $4.56M | Sell |
36,030
-2,194
| -6% | -$269K | 0.38% | 70 |
|
|
2025
Q1 | $4.89M | Sell |
38,224
-1,418
| -4% | -$192K | 0.43% | 65 |
|
|
2024
Q4 | $5.24M | Sell |
39,642
-1,971
| -5% | -$277K | 0.46% | 59 |
|
|
2024
Q3 | $6.06M | Sell |
41,613
-1,105
| -3% | -$160K | 0.52% | 58 |
|
|
2024
Q2 | $5.86M | Sell |
42,718
-1,168
| -3% | -$156K | 0.56% | 53 |
|
|
2024
Q1 | $6.02M | Sell |
43,886
-708
| -2% | -$96.7K | 0.6% | 53 |
|
|
2023
Q4 | $6.06M | Sell |
44,594
-1,590
| -3% | -$194K | 0.64% | 51 |
|
|
2023
Q3 | $5.65M | Sell |
46,184
-549
| -1% | -$69.8K | 0.65% | 49 |
|
|
2023
Q2 | $5.93M | Sell |
46,733
-996
| -2% | -$129K | 0.66% | 49 |
|
|
2023
Q1 | $6.16M | Sell |
47,729
-337
| -0.7% | -$44.1K | 0.72% | 47 |
|
|
2022
Q4 | $6.31M | Buy |
48,066
+486
| +1% | +$62.8K | 0.77% | 41 |
|
|
2022
Q3 | $5.57M | Buy |
47,580
+526
| +1% | +$65.3K | 0.75% | 39 |
|
|
2022
Q2 | $5.54M | Sell |
47,054
-675
| -1% | -$80.1K | 0.78% | 41 |
|
|
2022
Q1 | $6.22M | Buy |
47,729
+3,415
| +8% | +$445K | 0.74% | 44 |
|
|
2021
Q4 | $6.76M | Buy |
44,314
+121
| +0.3% | +$18.7K | 0.76% | 45 |
|
|
2021
Q3 | $7.14M | Sell |
44,193
-93
| -0.2% | -$15.7K | 0.88% | 37 |
|
|
2021
Q2 | $7.25M | Sell |
44,286
-850
| -2% | -$131K | 0.88% | 37 |
|
|
2021
Q1 | $6.8M | Sell |
45,136
-1,199
| -3% | -$190K | 0.89% | 37 |
|
|
2020
Q4 | $7.02M | Sell |
46,335
-495
| -1% | -$70.7K | 0.97% | 30 |
|
|
2020
Q3 | $6.34M | Sell |
46,830
-123
| -0.3% | -$16.7K | 1% | 27 |
|
|
2020
Q2 | $6.42M | Sell |
46,953
-435
| -0.9% | -$55.5K | 1.09% | 26 |
|
|
2020
Q1 | $5.11M | Sell |
47,388
-264
| -0.6% | -$30.4K | 1.07% | 28 |
|
|
2019
Q4 | $5.74M | Sell |
47,652
-570
| -1% | -$63.6K | 0.95% | 34 |
|
|
2019
Q3 | $4.8M | Sell |
48,222
-780
| -2% | -$81.6K | 0.85% | 41 |
|
|
2019
Q2 | $5.35M | Sell |
49,002
-770
| -2% | -$81.9K | 0.97% | 38 |
|
|
2019
Q1 | $5.57M | Buy |
49,772
+2,825
| +6% | +$310K | 1.06% | 33 |
|
|
2018
Q4 | $4.53M | Sell |
46,947
-3,450
| -7% | -$366K | 1.11% | 31 |
|
|
2018
Q3 | $6.14M | Buy |
50,397
+199
| +0.4% | +$23.4K | 1.15% | 29 |
|
|
2018
Q2 | $5.51M | Buy |
50,198
+607
| +1% | +$64.9K | 1.09% | 33 |
|
|
2018
Q1 | $5.29M | Sell |
49,591
-11,960
| -19% | -$1.33M | 1.08% | 32 |
|
|
2017
Q4 | $6.57M | Buy |
61,551
+12,960
| +27% | +$1.39M | 1.02% | 33 |
|
|
2017
Q3 | $5.4M | Buy |
48,591
+756
| +2% | +$80.8K | 1.19% | 26 |
|
|
2017
Q2 | $4.94M | Buy |
47,835
+9,012
| +23% | +$888K | 1.12% | 28 |
|
|
2017
Q1 | $3.77M | Buy |
38,823
+1,347
| +4% | +$129K | 1.16% | 25 |
|
|
2016
Q4 | $3.31M | Sell |
37,476
-2,280
| -6% | -$208K | 1.07% | 28 |
|
|
2016
Q3 | $3.84M | Sell |
39,756
-825
| -2% | -$78.5K | 1.21% | 26 |
|
|
2016
Q2 | $3.48M | Sell |
40,581
-495
| -1% | -$44.4K | 1.11% | 29 |
|
|
2016
Q1 | $3.57M | Sell |
41,076
-945
| -2% | -$84.5K | 1.17% | 27 |
|
|
2015
Q4 | $4.74M | Sell |
42,021
-1,470
| -3% | -$160K | 1.58% | 20 |
|
|
2015
Q3 | $4.4M | Sell |
43,491
-246
| -0.6% | -$29.5K | 1.48% | 22 |
|
|
2015
Q2 | $5.38M | Sell |
43,737
-462
| -1% | -$55.3K | 1.67% | 19 |
|
|
2015
Q1 | $5.06M | Buy |
44,199
+9,999
| +29% | +$1.1M | 1.55% | 20 |
|
|
2014
Q4 | $3.46M | Sell |
34,200
-10,884
| -24% | -$1.06M | 1.34% | 26 |
|
|
2014
Q3 | $4.11M | Sell |
45,084
-1,605
| -3% | -$141K | 1.27% | 25 |
|
|
2014
Q2 | $4M | Sell |
46,689
-3,735
| -7% | -$294K | 1.22% | 27 |
|
|
2014
Q1 | $3.97M | Sell |
50,424
-1,656
| -3% | -$138K | 1.24% | 27 |
|
|
2013
Q4 | $3.94M | Sell |
52,080
-1,110
| -2% | -$78.8K | 1.24% | 28 |
|
|
2013
Q3 | $3.72M | Buy |
53,190
+294
| +0.6% | +$19.3K | 1.26% | 30 |
|
|
2013
Q2 | $3.07M | Buy |
+52,896
| New | +$3.06M | 1.09% | 33 |
|
Other funds holding IBB
CB
Colonial Trust Advisors's IBB Position: Q1 2026 in Review
Colonial Trust Advisors reduced its iShares Biotechnology ETF (IBB) stake by 4.3% in Q1 2026, selling an estimated $246K and leaving 31,947 shares worth $5.39M. The position accounts for 0.42% of the portfolio, ranked #69.
Colonial Trust Advisors first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.25M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Colonial Trust Advisors held 31,947 shares of iShares Biotechnology ETF worth $5.39M as of Q1 2026.
- Colonial Trust Advisors sold 1,439 iShares Biotechnology ETF shares in Q1 2026, an estimated $246K.
- iShares Biotechnology ETF made up 0.42% of Colonial Trust Advisors's portfolio in Q1 2026, its #69 holding.
- Colonial Trust Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
- Colonial Trust Advisors's iShares Biotechnology ETF position peaked at $7.25M in Q2 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.